Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
OTDNET webinar 8th May 2013 Today’s session 08:30 Joanne 12yo 08:45 Ruby 8yo 09:00 Jeremy 57yo 09:15 Haviva 62yo 09:30 Ally 3yo 10:00 Eric 57yo 12 yr old Joanne It is Monday afternoon. She is brought by her mother Susan. Both are patients of the practice, though Joanne has not been seen for some years. Joanne had a cold 2 weeks ago and missed a couple of days at school. Over the weekend Joanne felt quite unwell and Susan was concerned enough to take her to an after hours GP. The GP diagnosed asthma, prescribed Seretide MDI 250/25 1 puff bd and advised Susan to follow-up with her GP in a couple of weeks. 12 yr old Joanne Susan tells you that she was not impressed with the service from the after hours GP. He asked very few questions, performed a cursory examination and then stated the problem was asthma while writing the prescription. She states the consultation lasted less than 5 minutes. She has used the internet to research the medication and cannot understand why the Seretide inhaler was prescribed. She is particularly concerned about the product containing ‘steroids’. In order to make a judgement as to whether Joanne has asthma, what key features in her history do you look for? History of present episode • Episodes of wheeze with or without shortness or breath, chest tightness, cough, breathlessness or wheeze at night • Chest pain associated with the symptoms • Previous inhaler use. If used, what happened? Past history • Recurring episodes of wheeze with or without shortness of breast, chest tightness and/or the symptoms occurring with other triggers such as season, air temperature, URTIs, exposure to cigarette smoke, exposure to aeroallergens • History of allergic rhinitis and/or atopic dermatitis. • History suggesting a cause for the shortness of breath other than that associated with the respiratory system • Have any medications been taken? Family history • Asthma or atopic disease in siblings • Exposure to environmental tobacco smoke 12 yr old Joanne Using the National Asthma Council Australia’s Asthma Management Handbook approach, describe the patterns of asthma in children. 12 yr old Joanne Joanne confirms she has wheeze with her cold, felt chest tightness and was short of breath. She has noticed this several times over the past couple of years, usually but not always, in the context of a cold. Sometimes it occurred at night. The frequency of these episodes were more than 6 weeks apart. She had eczema in the first 6 months of life. She is fully immunised and has had no major illness. Her growth and development are normal. She is not taking any medication. Her physical examination today is normal. What is your diagnosis? List in note form only, up to four (4) key elements of management? The most likely diagnosis is infrequent episodic asthma. Key components of asthma management include; • Education about the condition and its management • A written asthma action plan • Appropriate use of medications • Regular review 12 yr old Joanne Describe the drug treatment options for episodic asthma in children. Infrequent episodic asthma is treated with inhaled short-acting beta2 agonists as required. Frequent episodic asthma can often be well controlled with low-dose inhaled corticosteroids or montelukast or sodium cromoglycate. Treatment is identical to the initial treatment for persistent asthma. However, children with frequent episodic asthma are often affected only during winter and may require preventive therapy only during those months. 12 yr old Joanne Describe the drug treatment options for persistent asthma in children. Inhaled corticosteroids are the most effective preventive therapy in children with asthma. Montelukast or sodium cromoglycate are alternatives to inhaled corticosteroids. If control is not achieved after a 4-week trial of montelukast, low-dose inhaled corticosteroids should be trialled instead. In addition, use a short-acting beta agonist for symptomatic relief, as required. If inhaled corticosteroids are initiated but improvement does not occur over 4-8 weeks, then review the diagnosis, inhaler technique and adherence. If all are satisfactory but symptoms persist, add montelukast or a long-acting beta agonist. If frequent short-acting beta agonist use is still required, review the diagnosis. 12 yr old Joanne What is asthma severity? What is asthma control? How would you assess asthma control? Severity is classified according to the minimum amount of medication and intensity of interventions required to achieve and sustain good asthma control. Control is assessed as good, fair or poor according to recent reliever requirement, recent symptom frequency, nocturnal asthma, recent exacerbations, unplanned visits, current lung function (in adults and older children), and sometimes airway hyperresponsiveness. In practice, severity and control interact. Of the two concepts, control is most relevant to the day-to-day care of a patient with asthma. Ruby is having an asthma attack You are a GP at a small rural hospital. Ruby, aged 8 yrs, arrives at the hospital in a car driven by her mother Maria. She says that Ruby, who has a past history of asthma, has had a runny nose and a cough for 3 days. Her asthma has been worse over the last 2 days, and she has been requiring frequent salbutamol (12 puffs via spacer hourly for the last 2 hours). Despite salbutamol, Ruby has deteriorated. Maria noticed on the way to hospital that Ruby stopped talking and her breathing became more laboured. Ruby is having an asthma attack Ruby was born at 40 wks gestation and the delivery was uneventful. She was first diagnosed with asthma at the age of 3 yrs. She usually takes flixotide twice a day, and for her exacerbations of asthma needs salbutamol and oral prednisolone. On average, she has two to three exacerbations per year and has had five ward admissions since she was 3 years of age. Ruby's immunisations are up to date. She is allergic to penicillin. On examination Ruby is pale, has a tracheal tug, marked use of the accessory muscles of respiration and pronounced intercostal recession. She is unable to communicate with words. Her heart rate is 150 beats per minute, her respiratory rate is 30 breaths per minute, oxygen saturation is 84% in room air, she has a temperature of 36.8oC (tympanic), Glasgow coma score of 14, and her weight is 25 kg. Her chest is silent with the occasional expiratory wheeze. Ruby is having an asthma attack What are the most important elements of physical examination when assessing the severity of acute asthma in children? List up to five (5) elements of physical examination. In the assessment of severity of acute childhood asthma it is important to note the following primary features • general appearance/mental state • work of breathing (accessory muscle use, intercostal recession, tracheal tug) The following secondary features should also be noted: • initial SaO2 in room air • heart rate (tachycardia can be a sign of severity, but is also a side effect of beta agonists) • ability to speak Change in mental status is viewed as heralding an impending catastrophe. Initial SaO2 in room air, heart rate and ability to speak are helpful but less reliable features. Pulsus paradoxus and peak expiratory flow rate are not reliable indicators of severity. Wheeze is also not a good marker of severity. Ruby is having an asthma attack What are the risk factors for Ruby requiring admission to ICU? Patients at risk of requiring ICU management for asthma include those who have a history of: • ICU admissions, mechanical ventilation, or rapidly progressive and sudden respiratory deterioration • seizures or syncope during an asthma exacerbation • exacerbations precipitated by food • use of more than two beta-agonist metered dose inhaler (MDI) canisters per month • insufficient preventer therapy or poor adherence to preventer therapy • inability to recognise the severity of illness • associated depression or other psychiatric disorder. Ruby is having an asthma attack What investigations are needed? A CXR is not routinely indicated in the unintubated asthmatic child, as unexpected radiographic abnormalities are very rare. Exceptions are situations in which the clinical examination suggests the possibility of barotrauma or pneumonia. Arterial blood gases are not usually required. They are distressing and can cause a child with respiratory compromise to deteriorate further. Typical findings during the early phase of severe asthma are hypoxaemia and hypocapnia. With increasing airflow obstruction, hypercapnia will develop and indicate impending respiratory failure. However, the decision to intubate an asthmatic child should not depend on blood gas determination, but should be made on clinical grounds. The intubated patient, however, requires frequent blood gas determination, ideally from an indwelling arterial line, to assess adequacy of ventilatory support and progression of illness. Ruby is having an asthma attack How would you manage Ruby? Your initial management of Ruby is to: • transfer her and her mother to a resuscitation cubicle • aim for minimal handling and allow her to adopt the most comfortable position • ask for help from other medical staff within the hospital or in close proximity • administer oxygen to maintain SaO2 >92% • administer continuous nebulised salbutamol (0.5% undiluted) • administer nebulised ipratropium (3 doses x 250 mcg, 20 minutes apart, added to salbutamol) • obtain intravenous access – use comfort techniques such as dermal anaesthetic cream or patch, or distract her • take blood for FBC, UEC, lactate and venous blood gases as needed. Arterial blood gases are usually not needed unless intubated • administer methylprednisolone 1 mg/kg intravenously (IV) 6 hourly or hydrocortisone 2–4 mg/kg IV 4–6 hourly If Ruby is not responding to initial treatment or deteriorating further, contact the nearest tertiary paediatric hospital or paediatric retrieval service to arrange retrieval and transfer of Ruby to a paediatric ICU facility and commence drug infusions as shown below. Aminophylline • Loading dose: 10 mg/kg IV (maximum dose 500 mg) over 60 minutes. If Ruby were taking oral theophylline, do not give IV aminophylline – obtain a serum level. Administer a continuous infusion unless marked improvement has occurred following a loading dose. Magnesium sulphate • Dose: 50% magnesium sulphate – 0.1 ml/kg (50 mg/kg) over 20 minutes, then 0.06 ml/kg/hr (30 mg/kg/hour) by infusion. Aim to keep serum magnesium between 1.5 and 2.5 mmol/L. IV salbutamol • IV salbutamol may also be considered. However, there is limited evidence that it is beneficial. It does not appear to provide any benefits over nebulised salbutamol even in severe cases. Loading dose: 5 mcg/kg/min for 1 hour. This should be followed by an infusion in a dose of 1–2 mcg/kg/min. Ruby is having an asthma attack What potential treatment options exist if there is no improvement despite pharmacological treatment? List, in note form only, up to two (2) options. If there is no improvement despite pharmacological treatment, further treatment options include: • Non-invasive positive pressure ventilation (NPPV) • Intubation Ruby is having an asthma attack Where should Ruby be admitted? Despite whether Ruby requires intubation, she should be retrieved and transferred to a paediatric ICU by a paediatric retrieval service. Transfer should be considered in children with: • severe or critical asthma requiring intravenous therapy or respiratory support • escalating oxygen requirement • poor response to salbutamol or inability to wean salbutamol • a requirement for care above the level of that provided by the local hospital. Jeremy has chest pain and is breathless Jeremy, aged 57 yrs, is a storeman who lives alone. He presents to the local rural hospital where you are on call with sharp leftsided chest pain, shortness of breath and rigors. He has been unwell for 5 days with increasing shortness of breath. Five days ago he presented to another doctor who prescribed amoxycillin, which he has taken with no improvement in symptoms. He coughed up copious amounts of yellow sputum last night. Jeremy has a past history of ischaemic heart disease with an acute myocardial infarction and stent inserted into a coronary artery 2 yrs ago. He also has a past history of hypertension, GORD and excision of multiple melanomas. Jeremy was vaccinated against influenza 3 weeks ago. His current medications are aspirin, ramipril, atorvastatin and pantoprazole. Jeremy has chest pain and is breathless On examination, Jeremy is anxious with laboured breathing. He has reduced breath sounds at the right lung base. His temperature is 38.2ºC (tympanic), his pulse rate is 84 beats per minute (regular), blood pressure is 130/70 mmHg, respiratory rate is 24 breaths per minute and his oxygen saturation (Sa02) is 98% in room air. You decide it's likely Jeremy has community acquired pneumonia (CAP). How would you assess the severity of community acquired pneumonia? What clinical scoring tools are available to do this? It is important to assess the severity of pneumonia in order to make a decision on appropriate treatment and the need for hospital admission. Various scoring systems can also be used to assess the severity of pneumonia and include • Pneumonia Severity Index (PSI) (this uses information such as the patient's age, comorbidities, vital signs and blood tests) • CURB-65 (this uses information such as presence of confusion, urea level, respiratory rate, blood pressure and age >65 years) • CRB-65 (this uses similar information to CURB with the exception of urea) • SMART-COP There is no evidence supporting one scoring system over another. None can replace clinical assessment. Jeremy has chest pain and is breathless What investigations would you request? A CXR should be performed in all patients with presumed pneumonia. Investigations for the causal pathogen should also be done. This may include sputum gram stain and culture, and blood cultures in patients who require hospital admission. Arterial blood gases should be done on severely ill patients. Other investigations may be appropriate depending on the clinical circumstances. These include sputum for mycobacterium tuberculosis, urine antigen testing for pneumococcus, upper respiratory tract samples for polymerase chain reaction for respiratory tract viruses, and serological tests can be performed for Legionella spp. or mycoplasma pneumoniae if epidemiological reasons exist. Haematology and electrolytes may also be appropriate. Jeremy has chest pain and is breathless What are the organisms most likely to cause CAP in Australia? Streptococcus pneumoniae, mycoplasma pneumoniae and respiratory viruses are the most common aetiological agents for CAP in Australia. Atypical pneumonia (about one in five cases of CAP) is caused by organisms such as mycoplasma pneumoniae, chlamydia pneumoniae and Legionella spp. In one study, over 30% of culture positive CAP had co-infection with either a virus or atypical pathogen. Jeremy has chest pain and is breathless What organisms are most likely to cause CAP in immunocompromised patients? In immunocompromised patients, organisms may be atypical such as Klebsiella pneumoniae, Haemophilus influenzae or Morexella catarrhalis, or typical organisms can present atypically. For example, pneumonia due to Streptococcus pneumoniae may rapidly progress to septic shock, organ dysfunction and death. Jeremy has chest pain and is breathless Which antibiotic(s) would you prescribe for Jeremy and for how long? There are several antibiotic guidelines for CAP. For patients managed as an outpatient, Therapeutic Guidelines recommends the following: • amoxycillin 1g 8 hourly for 5–7 days OR • doxycycline 200mg for the first dose then 100mg doxycycline daily for a further 5 days OR • clarithromycin 250mg 12 hourly for 5–7 days Patients should be reviewed at 24–48 hours and if there is no improvement, combination therapy with amoxycillin plus either doxycycline or clarithromycin may be appropriate. Broad spectrum antibiotics and antibiotics not conforming with current guidelines risk Clostridium difficile associated diarrhoea and methicillin resistant Staphylococcus aureus (MRSA). They also have significantly higher rates of treatment failure and mortality. Studies on the aetiology of CAP in Australia show that less than 5% of identifiable pathogens are resistant to standard therapy. In Jeremy's case, it would be appropriate to continue amoxycillin and add either doxycycline or clarithromycin. Duration of treatment depends on his response. Jeremy has chest pain and is breathless You continue Jeremy's amoxycillin and add doxycycline. He responds well to treatment when reviewed 2 days later. Jeremy returns to see you 2 weeks later. He is feeling much better. Is immunisation useful in preventing CAP? Influenza vaccination prevents hospitalisation for influenza and pneumonia. It also prevents deaths from influenza-related conditions among the elderly. Pneumococcal immunisation of at-risk individuals and children has reduced morbidity and mortality. However, there has been an increase in non-vaccine strains, recombinants and increased antibiotic resistance. Haviva needs to lie down during class Haviva, aged 62 yrs, is a teacher at the local high school. She has a past history of diet-controlled type 2 diabetes, hypothyroidism, reflux oesophagitis, hypertension and hypercholesterolaemia. Her medications include thyroxine, pantoprazole, perindopril and atorvastatin. She is allergic to penicillin. It is early afternoon, and she presents after suddenly feeling ‘all light-headed’ during a class just after lunch. She was standing at the whiteboard when she felt unwell, sat down, then ended up lying down on the floor. After a few minutes the feeling resolved, but she continued to feel ‘not quite right’ and was having a little trouble catching her breath. The school principal drove her to your practice. Haviva needs to lie down during class Further history reveals that Haviva has been well up until today. She now complains of mild left-sided pleuritic chest discomfort and mild breathlessness. She has not had any fever, or cough, is not taking any hormonal therapy, and has not had any unintended weight loss, calf pain or swelling. Examination demonstrates a pulse of 85 beats per minute (regular), a BP of 130/70 mmHg, and a respiratory rate of 20 breaths per minute. She is afebrile. Haviva‘s chest is clear to auscultation and resonant to percussion. She has an otherwise normal examination. What is the likely diagnosis? What are your differential diagnoses? Haviva’s presentation with pleuritic chest pain and breathlessness raises the possibility of PE. Other important differential diagnoses for chest discomfort and breathlessness include cardiac causes (acute ischaemia, arrhythmia, pulmonary oedema and pericarditis) and respiratory causes (pleural effusion, pneumonia and pneumothorax). Haviva needs to lie down during class What investigations are available to confirm or exclude the likely diagnosis and where should these investigations be performed? Given the serious and possibly time-critical nature of many of the differential diagnoses, Haviva should be evaluated in an emergency department. Appropriate investigations include: • ECG and CXR to help assess for the presence of differential diagnoses, and to guide the choice of further investigations • Blood tests that may be useful include a FBC (to assess platelet numbers prior to commencing anticoagulation), estimation of renal function (prior to intravenous contrast administration), and a D-dimer in selected cases. D-dimer is a breakdown product of thrombin and elevated levels suggest the presence of thrombus. In the setting of a patient with a low pretest probability for PE, a negative D-dimer can be used to exclude the diagnosis of PE. Specific imaging tests to confirm a diagnosis of PE include • A VQ scan which uses lower doses of radiation (approx. 1.3 mSv), and is therefore preferred in younger patients. However, there is a significant possibility of a non-diagnostic scan, which would necessitate further testing, particularly in patients with a history of COPD or an abnormal initial CXR. • A CTPA is more sensitive and cost-effective than VQ scanning, however, risks include contrast reactions, renal impairment and a much higher radiation exposure (approx. 8–10 mSv). The latter is an important consideration in young women, where breast tissues receive a significant radiation dose. Haviva needs to lie down during class How do you determine the pre-test probability of your working diagnosis? How does this affect the choice of investigations? Most patients evaluated for a PE do not have a PE. Many investigations are time-consuming and involve exposure to contrast and radiation. Identification of patients with a low pre-test probability allows further risk-stratification with D-dimer testing to reduce the number of unnecessary imaging tests. Various clinical decision rules have been developed for the determination of the pre-test probability for PE. These include the Wells rule, the simplified Wells rule, the Geneva rule, the Charlotte rule and PERC (Pulmonary Embolism Rule out Criteria) rule. Haviva needs to lie down during class Haviva is transferred to hospital by ambulance, and is evaluated in the local emergency department. She has a CXR showing bibasal atelectasis, and a positive Ddimer. Subsequent CT pulmonary angiography confirms multiple small pulmonary emboli in subsegmental vessels throughout both lungs. What treatment is likely to be instituted for Haviva? Haviva is likely to have traditional management, which includes hospital admission and treatment with subcutaneous low molecular weight heparin (LMWH). Warfarin is likely to be commenced, and the LMWH continued until her INR is in the target range of 2–3. Haviva needs to lie down during class Three weeks later, Haviva’s daughter Naomi, who is 35 yrs old and 28 weeks pregnant, presents with pleuritic chest pain and mild breathlessness. You consider the diagnosis of pulmonary embolism (PE). How does diagnosis and management of suspected PE alter in the setting of pregnancy? Plasma D-dimer is more likely to be elevated in pregnancy than in the non-pregnant state. However, a negative D-dimer is still useful in a patient with low pre-test probability for PE, as further testing is not necessary. An elevated D-dimer should prompt lower limb ultrasonography, which may demonstrate a reason for anticoagulation without the use of ionising radiation. If an ultrasound of the lower limbs reveals no thrombus and a PE still needs to be excluded, then definitive imaging (VQ or CTPA) should occur. The estimated radiation absorbed by the fetus depends on the modality chosen and gestational. Appropriate initial chest imaging should be either a CTPA or perfusion-only lung scanning. If a PE is confirmed, then LMWH is recommended in the pregnant patient. Warfarin is not recommended during the first or third trimesters, and caution should be used if given in the second trimester. Anticoagulation should be continued for 3 months after delivery, and warfarin is safe in breastfeeding. Ally can’t stop coughing Terri has brought her child Ally, aged 3 yrs, in to see you. Ally has been coughing for 2 wks and Terri is concerned because last night ‘Ally couldn’t stop coughing.’ For 1 week prior to the onset of her cough, Ally had a clear runny nose and was ‘off her food’. Ally has no siblings and attends kindergarten on two mornings each week. On examination, Ally’s temperature is 37.2°C, her throat is not inflamed, her eardrums appear normal, there is no lymphadenopathy and her chest is clear. While sitting in your examination room, Ally has a prolonged bout of coughing followed by gagging. What is the most likely underling diagnosis? Write in note form your single (1) diagnosis. What are your differential diagnoses? Given the prolonged bout of coughing followed by gagging, pertussis is likely to be the working diagnosis. Infection with the Bordetella pertussis bacterium causes an acute respiratory illness characterised by a catarrhal phase, which is followed by a paroxysmal cough with or without the characteristic ‘whoop’ or post-tussive vomiting. Your differential diagnosis includes pertussis, infection due to respiratory syncytial virus or adenovirus and croup. Ally can’t stop coughing What investigation(s) would you order to confirm your working diagnosis? It would be appropriate to request a PCR and culture for pertussis (and respiratory viruses) on a nasopharyngeal swab given Ally’s history of 2 weeks of (nonparoxysmal) cough. Serology for pertussis could also be requested. Ally can’t stop coughing What treatment would you give Ally? What would you advise Terri about excluding Ally from other people? Ally has clinical features of pertussis and should be treated with antibiotics. Once symptoms are established antibiotics have little impact on the progression of the illness in the individual. However, for public health purposes the aim of antibiotic treatment is to reduce the patient’s infectious period to others. Antibiotics should be commenced within 3 weeks of the onset of cough. Ally should be excluded from kindergarten until she has received 5 days of antibiotic. In general, all cases with an association with childcare, family daycare, preschools, schools or other settings where there are susceptible individuals such as young children and infants should be excluded from those settings for 21 days after the onset of illness, or until they have received 5 days of a 7 day course of appropriate antibiotics (or the full 5 day course if using azithromycin). Ally’s suspected pertussis should be notified to the local public health unit or health department and advice sought on prophylaxis for contacts. In general, confirmed or probable cases of pertussis should be notified to your public health unit or health department as per the Australian National Notifiable Diseases case definition. Ally can’t stop coughing Ally’s nasopharyngeal swab result comes back pertussis PCR positive. You note that Ally is up to date with her childhood vaccinations. Terry is angry that her child has developed pertussis despite being fully vaccinated and wants to know how this was possible. What would you say to Terri? You could explain to Terri that pertussis vaccination is approximately 84–89% effective in preventing pertussis infection. Furthermore, protection from the vaccine does wane over time and booster doses are necessary. Consequently, it is not uncommon to see an older vaccinated child with pertussis infection. However, vaccination is very effective in preventing death or serious illness from pertussis in young children. You could commend Terri for having Ally fully vaccinated and reassure her that it is highly unlikely that Ally will develop severe disease. Ally can’t stop coughing In general, what contacts of a case of pertussis should receive chemoprophylaxis? In general, chemoprophylaxis is limited to a narrow range of contacts who have been exposed to an infectious case of pertussis in the previous 3 weeks and depends on the risk that it poses to young or unvaccinated infants. The definitions of eligible contacts (other than household contacts) for pertussis chemoprophylaxis are complex and best discussed with your local public health unit, which will follow up contacts. http://www.health.gov.au/internet/main/publishing.ns f/Content/cdna-song-pertussis.htm Ally can’t stop coughing Ally and Terri shared a household with David and Faith and their new baby while infectious with pertussis. David and Faith had received adult pertussis vaccination from their GP shortly after their baby was born. Should David and Faith receive chemoprophylaxis? Yes. While David and Faith are most likely to be protected by their recent vaccinations, the setting and potential for them to acquire infection from Ally and transmit it to their unimmunised newborn would warrant provision of chemoprophylaxis to ‘all family members when there is an unvaccinated infant in the household’. Eric is sleepy Eric, aged 57 yrs, is a truck driver who presents with sleepiness. He has a past history of ischaemic heart disease, type 2 diabetes, hypertension and hyperlipidaemia and he is on metformin, irbesartan, atorvastatin and aspirin. Eric smokes 25 cigarettes a day, and consumes 6 standard drinks of alcohol most nights of the week. Eric describes increasing sleepiness during the day that has been getting worse over the past 12 months. He will often fall asleep inappropriately. He is a loud snorer and his wife says she often stays awake at night because Eric stops breathing and she is worried that he won’t wake up. Recently, he has been more irritable and had a number of arguments with his daughters. On further questioning, Eric describes falling asleep at the traffic lights, although he says he has not been involved in any road traffic accidents. Eric is sleepy What is the most likely diagnosis? Write in note form, your single (1) diagnosis. Eric has symptoms suggestive of obstructive sleep apnoea (OSA). This is a common problem, affecting up to 25% of adult males in Australia. Common night-time clinical features include snoring, observed apnoeas, nocturnal choking and nocturia. Daytime sleepiness, or fatigue, is the most common daytime symptom with irritability or mood changes also commonly noted. Eric is sleepy What would you look for on physical examination? List up to four (4) suggestions. What clinical tools might help in your assessment? There are several examination findings that are useful in the assessment of suspected OSA. These include an elevated BMI, a crowded oropharynx (ie. large tonsils, a thick stumpy uvula and a large set back tongue), increased neck circumference and retrognathia. The most commonly used tool for assessment of the oropharynx is the modified mallampati (MMP) score, which strongly correlates with OSA. A neck circumference of greater than 40 cm has been found to have a sensitivity of 60% and a specificity of 93% for OSA independent of gender. However, clinical examination and history alone are able to predict only approximately 50% of cases of obstructive sleep apnoea, so further investigation is required. The Epworth Sleepiness Scale (ESS) is a useful tool that evaluates sleepiness by estimating the likelihood of dozing. A score of >10 is considered abnormal, with increasing scores reflecting increasing sleepiness. Eric is sleepy On examination Eric is obese, with a body mass index (BMI) of 38 kg/m2. He has a Modified Mallampati (MMP) score of 3 and a neck circumference of 45 cm. The remainder of his physical examination is normal. His score on the Epworth Sleepiness Scale (ESS) is 18/24. Eric is sleepy What investigations would you consider requesting to confirm your working diagnosis? The Australian Sleep Association divide investigations for OSA into four categories based on the level of evidence for their use. They range from a level one study, which consists of an inlaboratory polysomnography (PSG) undertaken with overnight observation, to a level four study, which consists of overnight pulse oximetry. In-laboratory PSG is the gold standard for the diagnosis of OSA and involves multiple channels to assess sleep quality, adequacy of ventilation, brain function, eye movements and heart rhythm, as well as chest wall and abdominal wall movements. Intermediate tests involve non-supervised home-based sleep studies with fewer monitoring channels. The use of home testing with portable monitors is limited to patients with a high pre-test probability of moderate to severe OSA. These studies are not recommended when there are comorbid conditions including moderate to severe pulmonary disease, cardiac failure or neuromuscular disease and should be avoided when diagnoses other than OSA are being considered. Eric is sleepy What advice would you give Eric regarding his work while he is being investigated? Austroads’ Assessing Fitness to Drive for commercial and private vehicle drivers provides information on OSA and driving. Patients suspected of having sleep apnoea should be warned about the potential effect on driving, and it is then their responsibility to avoid driving if sleepy. A person is not fit to hold an unconditional licence if they have self-reported episodes of sleepiness, drowsiness while driving, motor vehicle accident(s) caused by sleepiness or inattention. If they pose a significant driving risk in the opinion of the treating doctor they are also not fit to hold an unconditional licence. The legal responsibility for notifying the relevant state or territory authority regarding medical conditions, which may affect driving, lies with the driver once they are aware of the impact that their condition may have on driving. However, if there are concerns that the patient continues to drive despite appropriate advice and poses a public safety risk then direct reporting to the licensing authority should be considered. In New South Wales reporting is not mandatory. However, there are statutes that may protect health professionals who report without patient consent from litigation. Eric is sleepy Eric undergoes a sleep study. What is the diagnosis? Eric is sleepy Eric has severe OSA. The hypnogram shows frequent obstructive apnoeas in all sleep stages associated with profound arterial oxygen desaturations. There are frequent cortical arousals associated with these respiratory events, with resulting fragmented sleep. Consensus guidelines suggest that if respiratory events (obstructive apnoeas, hypopnoeas or respiratory event related arousals) on PSG occur at a frequency of >15 events/hour (also called the apnoea-hypopnoea index, or AHI) then a diagnosis of OSA is confirmed. OSA can also be confirmed in patients with >5 events/hour if there are associated symptoms. OSA severity is considered mild if the AHI is >5 events/hour but <15 events/hour, moderate if the AHI is ≥15 events/hour but <30 events/hour, and severe if the AHI is ≥30 events/hour. The significance of mild or moderate OSA is controversial and current practice in managing milder forms of OSA is variable. In many facilities, mild or moderate OSA is generally managed conservatively unless the patient wishes to commence active treatment, has significant comorbidities such as difficult to control hypertension or ischaemic heart disease, or if a patient has symptoms such as hypersomnolence that are clearly due to their OSA. Consider excluding non-sleep apnoea causes of hypersomnolence such as chronic sleep deprivation in a patient with mild to moderate sleep apnoea on PSG before offering active treatment. Eric is sleepy How would you treat this condition? OSA is a chronic condition requiring long-term collaborative management. • Treatment for OSA should be multimodal and include weight loss, exercise, avoidance of alcohol and sedatives and positional therapy (strategies to encourage lying on the side rather than the back). • Continuous positive airway pressure (CPAP) with heated humidification is the treatment of choice and should be offered to all patients with severe OSA. • Oral appliances (ie. mandibular advancement splints) are not as efficacious as CPAP, however, they may have a role in patients with mild to moderate OSA based on patient preference or intolerance of other management strategies including CPAP. • There is limited evidence to support the use of surgical techniques for OSA as first line treatment – they may be considered in patients with severe OSA who do not tolerate other treatments and have correctable anatomy. Eric is sleepy When would you advise Eric that he is able to return to work? A sleep specialist may grant a conditional commercial licence after review where there has been a satisfactory response to treatment and the patient has demonstrated treatment compliance. Annual review is recommended.